Total Payments
$10,614
2024 Payments
$2,549
Companies
56
Transactions
737
Medicare Patients
3,872
Medicare Billing
$439,987
Payment Breakdown by Category
Food & Beverage$10,439 (98.4%)
Education$174.80 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,439 | 730 | 98.4% |
| Education | $174.80 | 7 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,521 | 104 | $0 (2024) |
| Novo Nordisk Inc | $1,297 | 100 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $751.62 | 62 | $0 (2024) |
| Lilly USA, LLC | $624.77 | 50 | $0 (2024) |
| Amgen Inc. | $602.50 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $462.36 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $403.21 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $401.81 | 27 | $0 (2024) |
| PFIZER INC. | $381.11 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $365.58 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,549 | 165 | ABBVIE INC. ($684.18) |
| 2023 | $1,575 | 111 | AbbVie Inc. ($342.05) |
| 2022 | $1,931 | 128 | Novo Nordisk Inc ($404.36) |
| 2021 | $615.66 | 30 | Biohaven Pharmaceuticals, Inc. ($152.39) |
| 2020 | $456.47 | 25 | Boston Scientific Corporation ($107.03) |
| 2019 | $1,534 | 124 | Novo Nordisk Inc ($209.10) |
| 2018 | $1,013 | 95 | Janssen Pharmaceuticals, Inc ($201.97) |
| 2017 | $939.81 | 59 | Boehringer Ingelheim Pharmaceuticals, Inc. ($168.95) |
All Payment Transactions
737 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Neurology | ||||||
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ANTIBIOTIC | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Urgo Medical North America, LLC | VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: WOUND CLEANSER | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 694 | 1,076 | $201,541 | $81,318 |
| 2022 | 12 | 1,001 | 1,653 | $293,595 | $126,312 |
| 2021 | 12 | 968 | 1,643 | $264,987 | $119,844 |
| 2020 | 12 | 1,209 | 1,935 | $290,150 | $112,512 |
Total Patients
3,872
Total Services
6,307
Medicare Billing
$439,987
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 428 | $104,004 | $34,789 | 33.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 230 | 230 | $57,040 | $27,986 | 49.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $13,780 | $7,336 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 70 | 71 | $10,409 | $5,093 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 16 | $5,488 | $2,171 | 39.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 73 | $4,224 | $2,059 | 48.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 106 | $4,240 | $1,028 | 24.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 26 | 26 | $1,456 | $743.60 | 51.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 100 | $900.00 | $111.41 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 321 | 728 | $157,019 | $58,376 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 220 | 220 | $51,312 | $27,323 | 53.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 56 | 56 | $28,464 | $15,605 | 54.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 93 | 93 | $13,020 | $6,306 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 31 | $9,093 | $4,306 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $8,576 | $3,593 | 41.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 21 | $7,158 | $3,271 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 94 | 94 | $5,264 | $2,505 | 47.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $3,792 | $1,766 | 46.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 62 | 62 | $3,022 | $1,677 | 55.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 144 | $5,760 | $1,420 | 24.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 21 | 134 | $1,115 | $165.83 | 14.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 343 | 765 | $154,530 | $63,105 | 40.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 293 | 293 | $64,167 | $37,135 | 57.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 69 | 69 | $7,728 | $4,372 | 56.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 78 | $10,686 | $3,669 | 34.3% |
About Dr. Michael Davis, MD
Dr. Michael Davis, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124064225.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Davis, MD has received a total of $10,614 in payments from pharmaceutical and medical device companies, with $2,549 received in 2024. These payments were reported across 737 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($10,439).
As a Medicare-enrolled provider, Davis has provided services to 3,872 Medicare beneficiaries, totaling 6,307 services with total Medicare billing of $439,987. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Louisville, KY
- Active Since 06/20/2006
- Last Updated 12/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124064225
Products in Payments
- Ozempic (Drug) $633.92
- VRAYLAR (Drug) $597.44
- XARELTO (Drug) $592.24
- UBRELVY (Drug) $536.16
- ENTRESTO (Drug) $349.17
- JARDIANCE (Drug) $310.87
- ELIQUIS (Drug) $289.97
- NURTEC ODT (Drug) $280.90
- Kerendia (Drug) $275.13
- MOUNJARO (Drug) $240.48
- JANUVIA (Drug) $217.89
- Rybelsus (Drug) $214.57
- Aimovig (Biological) $214.55
- LINZESS (Drug) $190.62
- Cologuard Collection Kit (Device) $183.76
- VOQUEZNA (Drug) $181.51
- YUPELRI (Drug) $176.07
- SOLIQUA 100/33 (Biological) $172.23
- Vascepa (Drug) $171.97
- TRULICITY (Drug) $163.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400